Innovate for health csem 17.09.2014xxx
-
Upload
bisognanoc -
Category
Health & Medicine
-
view
111 -
download
0
Transcript of Innovate for health csem 17.09.2014xxx
![Page 1: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/1.jpg)
1IBM Technology Day 2013, Keynote B. Dubuis11.6.2013
Click to edit Master title style
© BD, ROI© 2013 IBM Corporation
Biotech, Medtech and Bioconvergence
Dr. Benoit Dubuis, President BioAlps & Inartis-Network, Executive Director Campus Biotech
17.09.2014
![Page 2: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/2.jpg)
HEALTH CARE “Medical revolution and new technologies”
The challenges
Towards bioconvergence
Our contribution
Anticipate the Future
![Page 3: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/3.jpg)
HEALTH CARE “Medical revolution and new technologies”
The challenges
Towards bioconvergence
Our contribution
Anticipate the Future
![Page 4: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/4.jpg)
Crossing Visions14.04.23 | 4
MAJOR CHALLENGESIN HEALTHCARE
Therapeutic challenges
Demographics
Cost
Access
Variation in clinical practice
Inefficient use of information
Fragmented care versus integrated care
Duplication, defensive medicine & waste
Protracted adoption of innovation
![Page 5: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/5.jpg)
Crossing Visions14.04.23 | 5
CAUSESOF DEATH
![Page 6: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/6.jpg)
Crossing Visions14.04.23 | 62
DEMOGRAPHICS:WE LIVELONGER
Life
Exp
ecta
ncy
at B
irth
Benchmark: Life expectancy in imperial Rome was ~ 30 years
1900 1950 2010 2050
CH: 80.5
CH: 84.7
Age 60 – 2 BillionAge 80 – 380 MillionAge 100 – 2 Million
Benchmark: Life expectancy in imperial Rome was ~ 30 years
Age 60 – 2 BillionAge 80 – 380 MillionAge 100 – 2 Million
![Page 7: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/7.jpg)
Crossing Visions14.04.23 | 7
HEALTH CARECOSTS
3
![Page 8: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/8.jpg)
Crossing Visions14.04.23 | 8
THE BURDEN OFCHRONIC DISEASES
Healthcare spending for people with chronic conditions
Nearly half of us will havechronic conditions by 2030:
DiabetesNeurodegenerative DiseaseObesityHypertensionArthritisAtherosclerosisStrokeCancerDegenerative Joint diseaseDegenerative Spine DiseaseObstructive Lung Disease
Healthcare spending for people without chronic conditions
Chronic conditionsaccount for 83% of health care spending4
![Page 9: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/9.jpg)
NEW NEEDS INNEURO-ENGINEERING
5
![Page 10: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/10.jpg)
Crossing Visions14.04.23 | 10
TOWARDHEALTHIER
LIFEPast model
Present model
Compressed morbidity model
Healthy life
Healthy life
DiseaseDisability
DiseaseDisability
Healthy life Life years gainedDiseaseDisability
![Page 11: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/11.jpg)
11IBM Technology Day 2013, Keynote B. Dubuis11.6.2013
Click to edit Master title style
MEDTECH “Medical revolution and new technologies”
The challenges
Towards Bioconvergence
Our contribution
Anticipate the Future
![Page 12: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/12.jpg)
Crossing Visions14.04.23 | 12
CHANGING FOCUSON HEALTH CARE
Technology convergence
Pharmacogenomics
3P medicine
Translational medicine
Wireless Health
![Page 13: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/13.jpg)
TOWARDS ANINTEGRATED HEALTH SYSTEM
Rx 2009
![Page 14: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/14.jpg)
Crossing Visions14.04.23 | 14
INNOVATION BYBIOCONVERGENCE
![Page 15: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/15.jpg)
Crossing Visions14.04.23 | 15
EXPLORE INTERFACES
![Page 16: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/16.jpg)
Crossing Visions14.04.23 | 16
NEXT GENERATIONPLATFORM TECHNOLOGIES
NEWPRODUCTS
NEWSOLUTIONS
![Page 17: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/17.jpg)
Crossing Visions14.04.23 | 18
THE STRENGTHOF THE
NETWORKCLINICAL CENTERS
ACADEMIC CENTERS
COREFACILITIES
INDUSTRY START-UPS
![Page 18: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/18.jpg)
191/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
Interdisciplinarity (science driven)
![Page 19: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/19.jpg)
What is a Stent
A small, mesh-like device made of metal
Acts as a support or scaffold, in keeping the vessel open
Stent helps to improve blood flow to the heart muscle and reduce
the pain of angina
80% of patients who have balloon angioplasty will have a stent
placed as well.
![Page 20: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/20.jpg)
History
Percutaneous transluminal coronary angioplasty (PTCA) by
Gruntzig in 1977
Puel and Sigwart, in 1986, deployed the first coronary stent to act
as a scaffold
In 2001, drug-eluting stents (DES) were introduced as a strategy
to minimize restenosis
![Page 21: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/21.jpg)
Types
Bare metal stents: Traditional method
May have an increased rate of
re-narrowing due to growth of scar
tissue in the stent, a condition called
Restenosis.
Drug-eluting stents:
Combat Restenosis
Coated with medications that are slowly released
to block the body's ability to form scar tissue
around the stent. The medication is delivered
directly to the site of the artery blockage.
![Page 22: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/22.jpg)
23IBM Technology Day 2013, Keynote B. Dubuis11.6.2013
Click to edit Master title style
MEDTECH “Medical revolution and new technologies”
The challenges
Towards an integrated health system
Our contribution
Innovation: The New Currency of
Competition
![Page 23: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/23.jpg)
Crossing Visions14.04.23 | 24
MICRO / NANO CLUSTER
BIOCLUSTER
A UNIQUE HUBFOR MEDTECH & BIOTECH
![Page 24: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/24.jpg)
WORLD-CLASSACADEMIC
INSTITUTIONS
Generate KnowledgeCreate Opportunities
![Page 25: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/25.jpg)
261/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
'evolutionary developmental biology'
Electronic health record'
Access to tools and knowledge
![Page 26: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/26.jpg)
271/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
The shift to patient-empowering, information-leveraging technologies
“PI” (patient-empowering and information-leveraging) technologies
![Page 27: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/27.jpg)
291/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
Molecular and personalized medicine
Proficient use of Information (e.health)
Genomic & physiology
Access, Cost and Quality of care
![Page 28: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/28.jpg)
301/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
INNOVATIONThe New Currency of Competition
![Page 29: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/29.jpg)
311/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
EXPLORE NEW AVENUES
![Page 30: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/30.jpg)
321/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
WHEREHISTORY WRITES
TowardsCampus Biotech
![Page 31: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/31.jpg)
331/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
WHEREHISTORY WRITESENSURING THAT
HISTORY GOES ON
![Page 32: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/32.jpg)
![Page 33: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/33.jpg)
Crossing Visions14.04.23 | 35
NEWPATHS
![Page 34: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/34.jpg)
361/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
![Page 35: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/35.jpg)
371/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
ACCELERATETECH TRANSFER
![Page 36: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/36.jpg)
381/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
SupportTechnology Transfer
![Page 37: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/37.jpg)
391/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
INARTIS NETWORK, NTN
R&D Projects(CTI)
R&D Projects(CTI)
Workshops
EventsWorkshops
Events
NetworkingNetworking
![Page 38: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/38.jpg)
40IBM Technology Day 2013, Keynote B. Dubuis11.6.2013
Click to edit Master title style
MEDTECH “Medical revolution and new technologies”
The challenges
Towards an integrated health system
Our contribution
Anticipate the Future
![Page 39: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/39.jpg)
Crossing Visions14.04.23 | 41
750 companties25’000 employees
![Page 40: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/40.jpg)
Crossing Visions14.04.23 | 42
Support the growthAnticipate the Future
Vitesse moyenne de croissance annuelle 95-00, 00-06Source: BAK, Basel Economics
![Page 41: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/41.jpg)
431/30/2014 www.republic-of-innovation.ch Dr. B. Dubuis
A Successfull biocluster
EstablishedaccesstoCapital
ExperiencedBusiness and
LawFirms
Carve-Outs/Spinouts
ExperiencedEntrepreneur Innovation
Initiatives
World-ClassResearch
Institutions
ExperiencedTechnicalPeople
World-ClassBusinessSchools
PhD’s
MBA’s
Early-StageCompany
Late-StageEmerging/Public
PublicIndustryLeader
IP
CreateValuearound IP
CreateValue
C://DUBUIS, 2009
![Page 42: Innovate for health csem 17.09.2014xxx](https://reader038.fdocuments.us/reader038/viewer/2022110122/55b1b25dbb61eb5d718b482b/html5/thumbnails/42.jpg)
© 2014 INARTIS
© 2013 IBM Corporation
Find the slides on:
www.republic-of-innovation.ch
Dr. Benoit [email protected]